Swiss Medical Board recommends rotator cuff surgery

19

Feb 2020

On January 31, 2020, the non-statutory HTA body, Swiss Medical Board, published the results of the report in which they compared the surgical and non-surgical treatment of rotator cuff tears.

Rotator cuff tears are among the most common locomotor injuries. Around 20 percent of people experience tears at some stage in their lives. This injury can greatly impact everyday activities and the quality of life of the patient. The injury can be treated both surgically and conservatively.  Conservative treatment may involve physiotherapy, pain medications, or steroid injections. Both approaches are effective.

Because of the frequency of this injury, the Swiss Medical Board decided to compare the efficacy, safety, and costs of the two treatment approaches. The following conclusions were drawn:

  • The surgery provides better results in terms of shoulder function and pain reduction. But, the treatments do not differ in terms of shoulder movement and muscle strength. Thus, overall differences are moderate
  • A five-years post-surgery model demonstrated that the surgical treatment costs CHF 7,000 more per patient, which equals to CHF 90 million on the annual level
  • However, each patient is different; therefore, some patients may experience greater benefits than others, with one of the two treatments
  • The Board decided to recommend the surgical treatment for this injury, but the patients should be carefully selected, based on their symptoms, lifestyle, and personal characteristics
  • The Board emphasized the need for a registry to document the long-term outcomes of different treatment methods

See the full news in English (change to German or French in the top-right corner) here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

24

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

11

Mar 2022

On February 07, 2022, the Dental and Pharmaceutical Benefits Agency has announced the withdrawal of the assessments of the PhysioMem PM 100 and CardioMem CM 100 XT and the finalization of the assessments of the Zenicor ECG, Coala Heart Monitor Pro, and KardiaMobile. For the conducted assessments, it was outlined that the portable devices provide more limited information than standard ECG measurements; therefore, it was mainly estimated for atrial fibrillation.

Read more

10

Mar 2022

In February 2022, the Finnish Coordinating Center for Health Technology Assessment announced the release of the seven accomplished rapid hospital assessments performed by the Helsinki, Tampere, and Oulu University Hospital. The accomplished rapid HTAs concern the diagnostic imaging, e-Health, endocrine, endoscopy, men’s health, neuromodulation technology groups.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more